Search results
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
FierceBiotech· 4 days agoBoehringer Ingelheim is making yet another bet that RNA therapies hold the key to treating...
CHOP Researchers Discover Underlying Biology Behind Fontan-Associated Liver Disease
Rome Sentinel· 2 days agoAs patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children's ...
How mRNA Is Rewriting the Rules of Cancer Treatment
SciTechDaily· 1 day agoMIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful...
Scientists Discover a New Signaling Pathway and Design a Novel Drug for Liver Fibrosis
Newswise· 1 day agoIn an advanced state, MASH can lead to cirrhosis, liver cancer and liver-related death. The cells that produce collagen in livers are called hepatic stellate cells (HSC). In healthy livers, ...